Elmwood Wealth Management, Inc. Xenon Pharmaceuticals Inc. Transaction History
Elmwood Wealth Management, Inc.
- $228 Million
- Q4 2024
A detailed history of Elmwood Wealth Management, Inc. transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Elmwood Wealth Management, Inc. holds 11,007 shares of XENE stock, worth $431,364. This represents 0.19% of its overall portfolio holdings.
Number of Shares
11,007
Previous 7,607
44.7%
Holding current value
$431,364
Previous $299,000
44.15%
% of portfolio
0.19%
Previous 0.13%
Shares
9 transactions
Others Institutions Holding XENE
# of Institutions
211Shares Held
70.3MCall Options Held
88.3KPut Options Held
28.8K-
Avoro Capital Advisors LLC New York, NY5.67MShares$222 Million3.36% of portfolio
-
Driehaus Capital Management LLC Chicago, IL4.6MShares$180 Million1.77% of portfolio
-
Wellington Management Group LLP Boston, MA3.84MShares$151 Million0.03% of portfolio
-
Braidwell LP Stamford, CT2.71MShares$106 Million3.02% of portfolio
-
Commodore Capital LP New York, NY2.7MShares$106 Million9.03% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $2.44B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...